In search of cyclooxygenase inhibitors, anti-Mycobacterium tuberculosis and anti-malarial drugs from Thai flora and microbes

Pharmacology and Therapeutics

Volumn 115, Issue 3, 2007, Pages 307-351

  Gale, George A ^a   Kirtikara, Kanyawim ^b   Pittayakhajonwut, Pattama ^b   Sivichai, Somsak ^b   Thebtaranonth, Yodhathai ^b   Thongpanchang, Chawanee ^b   Vichai, Vanicha ^b  

^a KING MONGKUT'S UNIVERSITY OF TECHNOLOGY THONBURI   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Bioactive compounds; Cyclooxygenase; Fungi; Inflammation; Malaria; Thailand; Tuberculosis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; ANTIMYCOBACTERIAL AGENT; ARTEETHER; ARTEMETHER; ARTEMISIN DERIVATIVE; ARTEMISININ; ARTESUNATE; CHLOROQUINE; CHLORPROGUANIL; CHLORPROGUANIL PLUS DAPSONE; CLINDAMYCIN; CYCLOGUANIL; DIHYDROARTEMISININ; DOXYCYCLINE; FANSIDAR; FOLIC ACID ANTAGONIST; HALOFANTRINE; ISOENZYME; MEFLOQUINE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZINAMIDE; QUININE; QUINOLINE DERIVATIVE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; DRUG MECHANISM; FLORA; HEART ARRHYTHMIA; HUMAN; INFLAMMATION; LUNG TUBERCULOSIS; MALARIA; MICROORGANISM; MYCOBACTERIUM TUBERCULOSIS; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PLASMODIUM; PRIORITY JOURNAL; REVIEW; STEVENS JOHNSON SYNDROME; THAILAND;

ANIMALS; ANTIMALARIALS; ANTITUBERCULAR AGENTS; CYCLOOXYGENASE INHIBITORS; FUNGI; HUMANS; MALARIA; MEDICINE, ORIENTAL TRADITIONAL; MYCOBACTERIUM TUBERCULOSIS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; THAILAND; TUBERCULOSIS;

EID: 34548542159     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.03.016     Document Type: Review

References (287)

1. Apisantiyakom S., Kittakoop P., Manyum T., Kirtikara K., Bremner J.B., and Thebtaranonth Y. Novel biologically active bibenzyls from Bauhinia saccocalyx PIERRE. Chem Biodivers 1 (2004) 1694-1701
2. Atherton C., Jones J., McKaig B., Bebb J., Cunliffe R., Burdsall J., et al. Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated study. Clin Gastroenterol Hepatol 2 (2004) 113-120
3. Awtry E.H., and Loscalzo J. Aspirin. Circulation 101 (2000) 1206-1218
4. Backer, C.A., van den Backhuizen, R.C.B. (1963-1968). (Vol. I-III). Groningen: Wolters-Noordhoff.
5. Baird J.K. Effectiveness of antimalarial drugs. N Engl J Med 352 (2005) 1565-1577
6. Ballou L.R., Botting R.M., Goorha S., Zhang J., and Vane J.R. Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci U S A 97 (2000) 10272-10276
7. Bamba H., Ota S., Kato A., and Matsuzaki F. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 245 (1998) 567-571
8. Bensen W.G., Fiechtner J.J., McMillen J.I., Zhao W.W., Yu S.S., Woods E.M., et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc 74 (1999) 1095-1105
9. Bhisutthibhan J., Pan X.Q., Hossler P.A., Walker D.J., Yowell C.A., Carlton J., et al. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem 273 (1998) 16192-16198
10. Biagini G.A., O'Neill P.M., Nzila A., Ward S.A., and Bray P.G. Antimalarial chemotherapy: young guns or back to the future?. Trends Parasitol 19 (2003) 479-487
11. Bias P., Buchner A., Klesser B., and Laufer S. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial. Am J Gastroenterol 99 (2004) 611-618
12. Black M.L. Sequential blockage as a theoretical basis for drug synergism. J Med Chem 6 (1963) 145-153
13. Blanco F.J., Buchner A., Bias P., Lammerich A., and Schulz U. Licofelone, an inhibitor of COX-1, COX-2 and 5-LOX, is as effective as naproxen and shows improved safety during 12 months of treatment in patients with osteoarthritis of the knee. Ann Rheum Dis 62 Suppl. 1 (2003) 262
14. Bloland P.B. Drug resistance in malaria (WHO/CDR/CSR/DRS/2001.4 4) (2001), World Health Organization, Geneva
15. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343 (2000) 1520-1528
16. Bombardieri S., Cattani P., Ciabattoni G., Di Munno O., Pasero G., Patrono C., et al. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsterioidal anti-inflammatory drugs. Br J Pharmacol 73 (1981) 893-901
17. Boonlaksiri C., Oonanant W., Kongsaeree P., Kittakoop P., Tantichareon M., and Thebtaranonth Y. An antimalarial stilbene from Artocarpus integer. Phytochemistry 54 (2000) 415-417
18. Boonphong S., Kittakoop P., Isaka M., Palittapongarnpim P., Jaturapat A., Danwisetkanjana K., et al. A new antimycobacterial, 3 β-acetoxy-15 α,22-dihydroxyhopane, from the insect pathogenic fungus Aschersonia tubulata. Planta Med 67 (2001) 279-281
19. Borstnik K., Paik I.H., Shapiro T.A., and Posner G.H. Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds. Int J Parasitol 32 (2002) 1661-1667
20. 2. J Neurochem 91 (2004) 1389-1397
21. Breder C.D., Dewitt D., and Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 355 (1985) 296-315
22. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352 (2005) 1092-1102
23. Brockman A., Price R.N., van Vugt M., Heppner D.G., Walsh D., Sookto P., et al. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg 94 (2000) 537-544
24. Brodie M., Hensby C., Parke A., and Gordon D. Is prostacycline the major pro-inflammatory prostanoid in joint fluid?. Life Sci 27 (1980) 603-608
25. Brooks P.M. The burden of musculoskeletal disease-a global perspective. Clin Rheumatol 25 (2006) 778-781
26. Byarugaba D.K. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents 24 (2004) 105-110
27. Cao C., Matsumura K., Yamagata K., and Watanabe Y. Cyclooxygenase-2 is induced in brain blood vessels during fever evoked by peripheral or central administration of tumor necrosis factor. Brain Res Mol Brain Res 56 (1998) 45-56
28. Carvalho J.C., Silva M.F., Maciel M.A., Pinto A.C., Nunes D.S., Lima R.M., et al. Investigation of anti-inflammatory and antinociceptive activities of trans-dehydrocrotonin, a 19-nor-clerodane diterpene from Croton cajucara. Part 1. Planta Med 62 (1996) 402-404
29. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 99 (2002) 13926-13931
30. Chang C.H., Lin C.C., Yang J.J., Namba T., and Hattori M. Anti-inflammatory effects of emodin from Ventilago leiocarpa. Am J Chin Med 24 (1996) 139-142
31. Chanphen R., Thebtaranonth Y., Wanauppathamkul S., and Yuthavong Y. Antimalarial principles from Artemisia indica. J Nat Prod 61 (1998) 1146-1147
32. Chinworrungsee M., Kittakoop P., Isaka M., Rungrod A., Tanticharoen M., and Thebtaranonth Y. Antimalarial halorosellinic acid from the marine fungus Halorosellinia oceanica. Bioorg Med Chem Lett 11 (2001) 1965-1969
33. Chinworrungsee M., Kittakoop P., Isaka M., Chanphen R., Tantichareon M., and Thebtaranonth Y. Halorosellins A and B, unique isocoumarin glucosides from the marine fungus Halorosellinia oceanica. J Chem Soc Perkin Trans 1 (2002) 2473-2476
34. Chinworrungsee M., Kittakoop P., Isaka M., Maithip P., Supothina S., and Thebtaranonth Y. Isolation and structure elucidation of a novel antimalarial macrocyclic polylactone, menisporopsin A, from the fungus Menisporopsis theobromae. J Nat Prod 67 (2004) 689-692
35. Chivian E. Environment and health: 7. Species loss and ecosystem disruption-the implications for human health. CMAJ 164 (2001) 66-69
36. Choi S.H., Langenbach R., and Bosetti F. Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis. J Neurochem 98 (2006) 801-811
37. Chumkaew P., Karalai C., Ponglimanont C., and Chantrapromma K. Antimycobacterial activity of phorbol esters from the fruits of Sapium indicum. J Nat Prod 66 (2003) 540-543
38. Claeson P., Panthong A., Tuchinda P., Reutrakul V., Kanjanapothi D., Taylor W.C., et al. Three non-phenolic diarylheptanoids with anti-inflammatory activity from Curcuma xanthorrhiza. Planta Med 59 (1993) 451-454
39. Claeson P., Pongprayoon U., Sematong T., Tuchinada P., Reutrakul V., Soontornsaratune P., et al. Non-phenolic linear diarylheptanoids from Curcuma xanthorrhiza: a novel type of topical anti-inflammatory agents: structure-activity relationship. Planta Med 62 (1996) 236-240
40. Collins L., and Franzblau S.G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41 (1997) 1004-1009
41. Collins W.E., and Jeffery G.M. Plasmodium ovale: parasite and disease. Clin Microbiol Rev 18 (2005) 570-581
42. Corbett E.L., Marston B., Churchyard G.J., and De Cock K.M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367 (2006) 926-937
43. Cowman A.F., Galatis D., and Thompson J.K. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci U S A 91 (1994) 1143-1147
44. Desjardins R.E., Canfield C.J., Haynes J.D., and Chulay J.D. Quantitative assessment of antimalaria activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16 (1979) 710-718
45. Dettrakul S., Kittakoop P., Isaka M., Nopichai S., Suyarnsestakorn C., Tanticharoen M., et al. Antimycobacterial pimarane diterpenes from the Fungus Diaporthe sp. Bioorg Med Chem Lett 13 (2003) 1253-1255
46. DeWitt D.L., and Meade E.A. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys 306 (1993) 94-102
47. Di Perri G., and Bonora S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?. J Antimicrob Chemother 54 (2004) 593-602
48. Di Rosa M., Giroud J.P., and Willoughby D.A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 104 (1971) 15-29
49. Dickinson J.M., and Mitchison D.A. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am Rev Respir Dis 123 (1981) 367-371
50. Dorn A., Stoffel R., Matile H., Bubendorf A., and Ridley R.G. Malarial haemozoin beta-haematin supports haeme polymerization in the absence of protein. Nature 374 (1995) 269-271
51. Dover L.G., Cerdeno-Tarraga A.M., Pallen M.J., Parkhill J., and Besra G.S. Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae. FEMS Microbiol Rev 28 (2004) 225-250
52. Eckstein-Ludwig U., Webb R.J., Van Goethem I.D., East J.M., Lee A.G., Kimura M., et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424 (2003) 957-961
53. Emery P., Zeidler H., Kvien T.K., Guslandi M., Naudin R., Stead H., et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 354 (1999) 2106-2111
54. 2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol (Lond) 495 (1996) 429-440
55. Espinal M.A. The global situation of MDR-TB. Tuberculosis (Edinb) 83 (2003) 44-51
56. Famin O., and Ginsburg H. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Biochem Pharmacol 63 (2002) 393-398
57. Famin O., Krugliak M., and Ginsburg H. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. Biochem Pharmacol 58 (1999) 59-68
58. Ferreira S. Prostaglandins, aspirin-like drugs and analgesia. Nature 240 (1972) 200-203
59. Ferreira M.U., da Silva Nunes M., and Wunderlich G. Antigenic diversity and immune evasion by malaria parasites. Clin Diagn Lab Immunol 11 (2004) 987-995
60. Fichera M.E., and Roos D.S. A plastid organelle as a drug target in apicomplexan parasites. Nature 390 (1997) 407-409
61. Fitzgerald G.A. Coxibs and cardiovascular disease. N Engl J Med 351 (2004) 1709-1711
62. Foley M., and Tilley L. Quinoline antimalarials: Mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 79 (1998) 55-87
63. Foote S.J., Galatis D., and Cowman A.F. Amino acid in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci U S A 87 (1990) 3014-3017
64. Funk C. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
65. Furberg C.D., Psaty B.M., and FitzGerald G.A. Parecoxib, valdecoxib, and cardiovascular risk. Circulation 111 (2005) 249
66. Gardiner D.L., McCarthy J.S., and Trenholme K.R. Malaria in the post-genomics era: light at the end of the tunnel or just another train?. Postgrad Med J 81 (2005) 505-509
67. Gierse J.K., Koboldt C.M., Walker M.C., Seibert K., and Isakson P.C. Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339 Pt 3 (1999) 607-614
68. Ginsburg H. Should chloroquine be laid to rest?. Acta Trop 96 (2005) 16-23
69. Ginsburg H., and Geary T.G. Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials. Biochem Pharmacol 36 (1987) 1567-1576
70. Ginsburg H., and Krugliak M. Quinoline-containing antimalarials-mode of action, drug resistance and its reversal. An update with unresolved puzzles. Biochem Pharmacol 43 (1992) 63-70
71. Ginsburg H., Ward S.A., and Bray P.G. An integrated mode of chloroquine action. Parasitol Today 15 (1999) 357-360
72. Goetzl E.J., An S., and Smith W.L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 9 (1995) 1051-1058
73. Gogtay N.J., Kadam V.S., Karnad D.R., Kanbur A., Kamtekar K.D., and Kshirsagar N.A. Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India. Ann Trop Med Parasitol 94 (2000) 519-520
74. Gomez J.E., and McKinney J.D. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 84 (2004) 29-44
75. Gorman C. The Hoabinhian and after: subsistence patterns in Southeast Asia during the Late Pleistocene and early recent periods. World Archaeol 2 (1971) 300-320
76. Graham S.M., Daley H.M., Banerjee A., Salaniponi F.M., and Harries A.D. Ethambutol in tuberculosis: time to reconsider?. Arch Dis Child 79 (1998) 274-278
77. Gray D., Piprell C., and Graham M. National Parks of Thailand (1994), Thai Wattana Panich, Bangkok
78. Greenwood B.M., Bojang K., Whitty C.J., and Targett G.A. Malaria. Lancet 365 (2005) 1487-1498
79. Gregson A., and Plowe C.V. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev 57 (2005) 117-145
80. Hammond P.M. Insect abundance and diversity in the Dumoga-bone National Park, N. Sulawesi with special reference to the beetle fauna of lowland rainforest in the Torault region. In: Knight W.J., and Holloway J.M. (Eds). Insects and the Rain Forests of S.E. Asia (Wallacea) (1990), Royal Entomological Society, London 197-254
81. Harris R.C., McKanna J.A., Akai Y., Jacobson H.R., Dubois R.N., and Breyer M.D. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94 (1994) 2504-2510
82. Harvey R.J. Synergism in the folate pathway. Rev Infect Dis 4 (1982) 255-260
83. Hawkey C., Kahan A., Steinbruck K., Alegre C., Baumelou E., Begaud B., et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol 37 (1998) 937-945
84. Hawksworth D.L. Second fungal genome sequenced. Mycol Res 106 (2002) 386
85. Haynes R.K. Artemisinin and derivatives: the future for malaria treatment?. Curr Opin Infect Dis 14 (2001) 719-726
86. Haynes R.K., Pai H.H.O., and Voerste A. Ring opening of artemisinin (quinghaosu) and dihydroartemisinin and interception of the open hydroperoxides with formation of N-oxides-a chemical mode of antimalarial mode of action. Tetrahedron Lett 40 (1999) 15-18
87. Herschman H.R. Prostaglandin synthase 2. Biochim Biophys Acta 1299 (1996) 125-140
88. Heywood V.H. Global Biodiversity Assessment (1995), Cambridge University Press, Cambridge
89. Hla T., and Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 89 (1992) 7384-7388
90. Hong Y.L., Yang Y.Z., and Meshnick S.R. The interaction of artemisinin with malarial hemozoin. Mol Biochem Parasitol 63 (1994) 121-128
91. 4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 34 (1993) 742-747
92. Hunt R.H., Harper S., Callegari P., Yu C., Quan H., Evans J., et al. Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib. Aliment Pharmacol Ther 17 (2003) 201-210
93. Hunt R.H., Harper S., Watson D.J., Yu C., Quan H., Lee M., et al. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. Am J Gastroenterol 98 (2003) 1725-1733
94. Hyde J.E. The dihydrofolate reductase-thymidylate synthase gene in the drug resistance of malaria parasites. Pharmacol Ther 48 (1990) 45-49
95. Hyde K.D., Jones E.B.G., Leano E., Pointing S.B., Poonyth A.D., and Vrijmoed L.L.P. Role of fungi in marine ecosystems. Biodivers Conserv 7 (1998) 1147-1161
96. Ichihara Y., Takeya K., Hitotsuyanagi Y., Morita H., Okuyama S., Suganuma M., et al. Cajucarinolide and isocajucarinolide: anti-inflammatory diterpenes from Croton cajucara. Planta Med 58 (1992) 549-551
97. Intahphuak S., Panthong A., Kanjanapothi D., Taesotikul T., Krachangchaeng C., and Reutrakul V. Anti-inflammatory and analgesic activities of Mallotus spodocarpus Airy shaw. J Ethnopharmacol 90 (2004) 69-72
98. Isaka M., Punya J., Lertwerawat Y., Tantichareon M., and Thebtaranonth Y. Antimalarial activity of macrocyclic trichothecenes isolated from the fungus Myrothecium verrucaria. J Nat Prod 62 (1999) 329-331
99. Isaka M., Jaturapat A., Kladwang W., Punya J., Lertwerawat Y., Tanticharoen M., et al. Antiplasmodial compounds from the wood-decayed fungus Xylaria sp. BCC 1067. Planta Med 66 (2000) 473-475
100. Isaka M., Jaturapat A., Rukseree K., Danwisetkanjana K., Tanticharoen M., and Thebtaranonth Y. Phomoxanthones A and B, novel xanthone dimers from the endophytic fungus Phomopsis species. J Nat Prod 64 (2001) 1015-1018
101. Isaka M., Kongsaeree P., and Thebtaranonth Y. Bioxanthracenes from the insect pathogenic fungus Cordyceps pseudomilitaris BCC 1620: II. Structure elucidation. J Antibiot (Tokyo) 54 (2001) 36-43
102. Isaka M., Tanticharoen M., Kongsaeree P., and Thebtaranonth Y. Structures of cordypyridones A-D, antimalarial N-hydroxy- and N-methoxy-2-pyridones from the insect pathogenic fungus Cordyceps nipponica. J Org Chem 66 (2001) 4803-4808
103. Isaka M., Jaturapat A., Kramyu J., Tanticharoen M., and Thebtaranonth Y. Potent in vitro antimalarial activity of metacycloprodigiosin isolated from Streptomyces spectabilis BCC 4785. Antimicrob Agents Chemother 46 (2002) 1112-1113
104. Isaka M., Suyarnsestakorn C., Tanticharoen M., Kongsaeree P., and Thebtaranonth Y. Aigialomycins A-E, new resorcylic macrolides from the marine mangrove fungus Aigialus parvus. J Org Chem 67 (2002) 1561-1566
105. Isaka M., Kittakoop P., Kirtikara K., Hywel-Jones N.L., and Thebtaranonth Y. Bioactive substances from insect pathogenic fungi. Acc Chem Res 38 (2005) 813-823
106. Isaka M., Palasarn S., Kocharin K., and Saenboonrueng J. A cytotoxic xanthone dimer from the entomopathogenic fungus Aschersonia sp. BCC 8401. J Nat Prod 68 (2005) 945-946
107. Isaka M., Palasarn S., Rachtawee P., Vimuttipong S., and Kongsaeree P. Unique diketopiperazine dimers from the insect pathogenic fungus Verticillium hemipterigenum BCC 1449. Org Lett 7 (2005) 2257-2260
108. Isaka M., Palasarn S., Sriklung K., and Kocharin K. Cyclohexadepsipeptides from the insect pathogenic fungus Hirsutella nivea BCC 2594. J Nat Prod 68 (2005) 1680-1682
109. Isaka M., Rugseree N., Maithip P., Kongsaeree P., Prabpai S., and Thebtaranonth Y. Hirsutellones A-E, antimycobacterial alkaloids from the insect pathogenic fungus Hirsutella nivea BCC 2594. Tetrahedron 61 (2005) 5577-5583
110. Isaka M., Prathumpai W., Wongsa P., and Tanticharoen M. Hirsutellone F, a dimer of antitubercular alkaloids from the seed fungus Trichoderma species BCC 7579. Org Lett 8 (2006) 2815-2817
111. Iskander M.N., Song Y., Coupar I.M., and Jiratchariyakul W. Antiinflammatory screening of the medicinal plant Gynura procumbens. Plant Foods Hum Nutr 57 (2002) 233-244
112. Jaturapat A., Isaka M., Hywel-Jones N.L., Lertwerawat Y., Kamchonwongpaisan S., Kirtikara K., et al. Bioxanthracenes from the insect pathogenic fungus. Cordyceps pseudomilitaris BCC 1620: I. Taxonomy, fermentation, isolation and antimalarial activity. J Antibiot (Tokyo) 54 (2001) 29-35
113. Jones E.B.G., and Hyde K.D. Introduction to Thai fungal diversity. In: Jones E.B.G., Tanticharoen M., and Hyde K.D. (Eds). Thai fungal diversity (2004), BIOTEC, Bangkok 7-35
114. Kain K.C., Gopinath R., Yau Y., Temahivong T., and Wongsrichanalai C. In vivo response of falciparum malaria to chloroquine in southern Thailand. J Infect Dis 170 (1994) 258-259
115. Kain K.C., Shanks G.D., and Keystone J.S. Malaria chemoprophylaxis in the age of drug resistance.I. Currently recommended drug regimens. Clin Infect Dis 33 (2001) 226-234
116. Kala C.P. Indigenous uses, population density, and conservation of threatened medicinal plants in protected areas of the Indian Himalayas. Conserv Biol 19 (2005) 368-378
117. Kamchonwongpaisan S., Nilanonta C., Tanchompoo B., Thebtaranonth C., Thebtaranonth Y., Yuthavong Y., et al. An antimalarial peroxide from Amomum krervanh Pierre. Tetrahedron Lett 36 (1995) 1821-1824
118. Kanokmedhakul S., Kanokmedhakul K., Phonkerd N., Soytong K., Kongsaeree P., and Suksamrarn A. Antimycobacterial anthraquinone-chromanone compound and diketopiperazine alkaloid from the fungus Chaetomium globosum KMITL-N0802. Planta Med 68 (2002) 834-836
119. Kanokmedhakul S., Kanokmedhakul K., Prajuabsuk T., Soytong K., Kongsaeree P., and Suksamrarn A. A bioactive triterpenoid and vulpinic acid derivatives from the mushroom Scleroderma citrinum. Planta Med 69 (2003) 568-571
120. Kanokmedhakul S., Kanokmedhakul K., Yodbuddee D., and Phonkerd N. New antimalarial bis-dehydroaporphine alkaloids from Polyalthia debilis. J Nat Prod 66 (2003) 616-619
121. Kirchgatter K., and Del Portillo H.A. Clinical and molecular aspects of severe malaria. An Acad Bras Cienc 77 (2005) 455-475
122. Kirk P.M., Cannon P.F., David J.C., and Stalpers J.A. Ainsworth and Bisby's dictionary of the fungi. (9th ed.). (2001), CABI Publishing, London
123. 2 biosynthesis in cyclooxygenase 1 or 2 null cells. J Exp Med 187 (1998) 517-523
124. Kittakoop P., Punya J., Kongsaeree P., Lertwerawat Y., Jintasirikul A., Tantichareon M., et al. Bioactive naphthoquionones from Cordyceps unilateralis. Phytochemistry 52 (1999) 453-457
125. Kittakoop P., Kirtikara K., Tantichareon M., and Thebtaranonth Y. Antimalarial preracemosols A and B, possible biogenetic precursors of racemosol from Bauhinia malabarica Roxb. Phytochemistry 55 (2000) 349-352
126. Kittakoop P., Wanasith S., Watts P., Kramyu J., Tanticharoen M., and Thebtaranonth Y. Potent antiviral potamogetonyde and potamogetonol, new furanoid labdane diterpenes from Potamogeton malaianus. J Nat Prod 64 (2001) 385-388
127. Kittakoop P., Nopichai S., Thongon N., Charoenchai P., and Thebtaranonth Y. Bauhinoxepins A and B: new antimycobacterial dibenzo[b,f]oxepins from Bauhinia saccocalyx. Helv Chim Acta 87 (2004) 175-179
128. Klayman D.L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228 (1985) 1049-1055
129. Kohler S., Delwiche C.F., Denny P.W., Tilney L.G., Webster P., Wilson R.J., et al. A plastid of probable green algal origin in Apicomplexan parasites. Science 275 (1997) 1485-1489
130. Konno K., Oizumi K., and Oka S. Mode of action of rifampin on mycobacteria. II. Biosynthetic studies on the inhibition of ribonucleic acid polymerase of Mycobacterium bovis BCG by rifampin and uptake of rifampin-14 C by Mycobacterium phlei. Am Rev Respir Dis 107 (1973) 1006-1012
131. Kujubu D.A., and Herschman H.R. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 267 (1992) 7991-7994
132. Kulmacz R.J., and Lands W.E. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. J Biol Chem 260 (1985) 12572-12578
133. Kurumbail R.G., Stevens A.M., Gierse J.K., McDonald J.J., Stegeman R.A., Pak J.Y., et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384 (1996) 644-648
134. Lanes S.F., Garcia Rodriguez L.A., and Hwang E. Baseline risk of gastrointestinal disorders among new users of meloxicam, ibuprofen, diclofenac, naproxen and indomethacin. Pharmacoepidemiol Drug Saf 9 (2000) 113-117
135. Lang T., and Greenwood B. The development of Lapdap, an affordable new treatment for malaria. Lancet Infect Dis 3 (2003) 162-168
136. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83 (1995) 483-492
137. Larsen K., and Hu C.-M.M. Myrsinaceae Vol. 6 (1996), Forest Herbarium, Royal Forest Department, Bangkok
138. Larsen K., Larsen S.S., and Vidal J.E. Leguminosae-Caesalpinioideae Vol. 4 (1984), Forest Herbarium, Royal Forest Department, Bangkok
139. Lastra-Gonzalez G., Manrique C.M., Govindarajan G., Whaley-Connell A., and Sowers J.R. Insights into the emerging cardiometabolic prevention and management of diabetes mellitus. Expert Opin Pharmacother 6 (2005) 2209-2221
140. Laupattarakasem P., Houghton P.J., and Hoult J.R. Anti-inflammatory isoflavonoids from the stems of Derris scandens. Planta Med 70 (2004) 496-501
141. Lety M.A., Nair S., Berche P., and Escuyer V. A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 41 (1997) 2629-2633
142. Li R.W., David Lin G., Myers S.P., and Leach D.N. Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol 85 (2003) 61-67
143. Li R.W., Leach D.N., Myers S.P., Leach G.J., Lin G.D., Brushett D.J., et al. Anti-inflammatory activity, cytotoxicity and active compounds of Tinospora smilacina Benth. Phytother Res 18 (2004) 78-83
144. Limmatvapirat C., Sirisopanaporn S., and Kittakoop P. Antitubercular and antiplasmodial constituents of Abrus precatorius. Planta Med 70 (2004) 276-278
145. Liu J.H., Zschocke S., Reininger E., and Bauer R. Inhibitory effects of Angelica pubescens f. biserrata on 5-lipoxygenase and cyclooxygenase. Planta Med 64 (1998) 525-529
146. Lodge D.J., Hawksworth D.L., and Ritchie B.J. Microbial diversity and tropical forest functioning. In: Orians G.H., Dirzo R., and Cushman J.H. (Eds). Biodiversity and Ecosystem Processes in Tropical Forests, Ecological Studies (1996), Springer-Verlag, Berlin 69-100
147. 2 synthase. Nat Struct Biol 2 (1995) 637-643
148. Loria P., Miller S., Foley M., and Tilley L. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and othe quinoline antimalarials. Biochem J 339 (1999) 363-370
149. Luxemburger C., Brockman A., Silamut K., Nosten F., van Vugt M., Gimenez F., et al. Two patients with falciparum malaria and poor in vivo responses to artesunate. Trans R Soc Trop Med Hyg 92 (1998) 668-669
150. Mackinnon M.J., and Read A.F. Virulence in malaria: an evolutionary viewpoint. Philos Trans R Soc Lond B Biol Sci 359 (2004) 965-986
151. Mamdani M., Juurlink D.N., Lee D.S., Rochon P.A., Kopp A., Naglie G., et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 363 (2004) 1751-1756
152. Martel-Pelletier J., Lajeunesse D., Reboul P., and Pelletier J.P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 62 (2003) 501-509
153. Maxwell J.F., and Elliott S. Vegetation and Vascular Flora of Doi Sutep-Pui National Park, Chiang Mai Province, Thailand Vol. 5 (2001), Biodiversity Research and Training Programme, Bangkok
154. McCammon M.T., Gillette J.S., Thomas D.P., Ramaswamy S.V., Rosas I.I., Graviss E.A., et al. Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region. Antimicrob Agents Chemother 49 (2005) 2210-2217
155. Mdluli K., Slayden R.A., Zhu Y., Ramaswamy S., Pan X., Mead D., et al. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science 280 (1998) 1607-1610
156. Meshnick S.R., Thomas A., Ranz A., Xu C.M., and Pan H.Z. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol 49 (1991) 181-189
157. Meshnick S.R., Yang Y.Z., Lima V., Kuypers F., Kamchonwongpaisan S., and Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother 37 (1993) 1108-1114
158. Mockenhaupt F.P. Mefloquine resistance in Plasmodium falciparum. Parasitol Today 11 (1995) 248-253
159. Mukherjee D., Nissen S.E., and Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286 (2001) 954-959
160. Mukherjee J.S., Rich M.L., Socci A.R., Joseph J.K., Viru F.A., Shin S.S., et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 363 (2004) 474-481
161. Myers N., Mittermeier R.A., Mittermeier C.G., da Fonseca G.A., and Kent J. Biodiversity hotspots for conservation priorities. Nature 403 (2000) 853-858
162. National Report on the Implementation of Convention on Biological Diversity, Thailand (2002), Office of Environmental Policy and Planning (OEPP), Ministry of Science, Technology and Environment, Bangkok
163. Newton P., and White N.J. Malaria: new developments in treatment and prevention. Annu Rev Med 50 (1999) 179-192
164. Nilanonta C., Isaka M., Kittakoop P., Palittapongarnpim P., Kamchonwongpaisan S., Pittayakhajonwut D., et al. Antimycobacterial and antiplasmodial cyclodepsipeptides from the insect pathogenic fungus Paecilomyces tenuipes BCC 1614. Planta Med 66 (2000) 756-758
165. Nilanonta C., Isaka M., Kittakoop P., Trakulnaleamsai S., Tanticharoen M., and Thebtaranonth Y. Precursor-directed biosynthesis of beauvericin analogs by the insect pathogenic fungus Paecilomyces tenuipes BCC 1614. Tetrahedron 58 (2002) 3355-3360
166. Nilanonta C., Isaka M., Chanphen R., Thong-Orn N., Tanticharoen M., and Thebtaranonth Y. Unusual enniatins produced by the insect pathogenic fungus Verticillium hemipterigenum: isolation and studies on precursor-directed biosynthesis. Tetrahedron 59 (2003) 1015-1020
167. Nilanonta C., Isaka M., Kittakoop P., Saenboonrueng J., Rukachaisirikul V., Kongsaeree P., et al. New diketopiperazines from the entomopathogenic fungus Verticillium hemipterigenum BCC 1449. J Antibiot (Tokyo) 56 (2003) 647-651
168. Olliaro P.L., Haynes R.K., Meunier B., and Yuthavong Y. Possible modes of action of the artemisinin-type compounds. Trends Parasitol 17 (2001) 122-126
169. O'Neill P.M., Bray P.G., Hawley S.R., Ward S.A., and Park B.K. 4-Aminoquinolines-past, present and future: a chemical perspective. Pharmacol Ther 77 (1998) 29-58
170. Onyebujoh P., Zumla A., Ribeiro I., Rustomjee R., Mwaba P., Gomes M., et al. Treatment of tuberculosis: present status and future prospects. Bull World Health Organ 83 (2005) 857-865
171. Ouellet M., and Percival M.D. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem J 306 Pt 1 (1995) 247-251
172. Paitayatat S., Tarnchompoo B., Thebtaranonth Y., and Yuthavong Y. Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX. J Med Chem 40 (1997) 633-638
173. Panthong A., Kanjanapothi D., Taesotikul T., Wongcome T., and Reutrakul V. Anti-inflammatory and antipyretic properties of Clerodendrum petasites S. Moore. J Ethnopharmacol 85 (2003) 151-156
174. Panthong A., Kanjanapothi D., Taesotikul T., Phankummoon A., Panthong K., and Reutrakul V. Anti-inflammatory activity of methanolic extracts from Ventilago harmandiana Pierre. J Ethnopharmacol 91 (2004) 237-242
175. Paramasivan C.N., and Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 120 (2004) 377-386
176. Pauli G.F., Case R.J., Inui T., Wang Y., Cho S., Fischer N.H., et al. New perspectives on natural products in TB drug research. Life Sci 78 (2005) 485-494
177. Pavelka K., Recker D.P., and Verburg K.M. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial. Rheumatology (Oxford) 42 (2003) 1207-1215
178. Perez S., Meckes M., Perez C., Susunaga A., and Zavala M.A. Anti-inflammatory activity of Lippia dulcis. J Ethnopharmacol 102 (2005) 1-4
179. Peterson D.S., Milhous W.K., and Wellems T.E. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A 87 (1990) 3018-3022
180. Petras J.M., Young G.D., Bauman R.A., Kyle D.E., Gettayacamin M., Webster H.K., et al. Arteether-induced brain injury in Macaca mulatta: I. The precerebellar nuclei: the lateral reticular nuclei, paramedian reticular nuclei, and perihypoglossal nuclei. Anat Embryol (Berl) 201 (2000) 383-397
181. Pittayakhajonwut P., Theerasilp M., Kongsaeree P., Rungrod A., Tanticharoen M., and Thebtaranonth Y. Pughiinin A, a sesquiterpene from the fungus Kionochaeta pughii BCC 3878. Planta Med 68 (2002) 1017-1019
182. Plowe C.V., Cortese J.F., Djimde A., Nwanyanwu O.C., Watkins W.M., Winstanley P., et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176 (1997) 1590-1596
183. Pongprayoon U., Sematong T., Tuchinda P., Claeson P., Reutrakul V., and Nahar N. Topical antiinflammatory activity of two pimarane diterpenes from Kaempferia pulchra. Phytother Res 10 (1996) 534-535
184. Posner G.H., Wang D., Cumming J.N., Oh C.H., French A.N., Bodley A.L., et al. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin. J Med Chem 38 (1995) 2273-2275
185. Prayoonrat P. Biodiversity of medicinal weeds in Chonburi Region, Thailand (2005) [Audiovisual material]
186. Price R.N. Artemisinin drugs: novel antimalarial agents. Expert Opin Investig Drugs 9 (2000) 1815-1827
187. Promsawan N., Kittakoop P., Boonphong S., and Nongkunsarn P. Antitubercular cassane furanoditerpenoids from the roots of Caesalpinia pulcherrima. Planta Med 69 (2003) 776-777
188. Puntumchai A., Kittakoop P., Rajviroongit S., Vimuttipong S., Likhitwitayawuid K., and Thebtaranonth Y. Lakoochins A and B, new antimycobacterial stilbene derivatives from Artocarpus lakoocha. J Nat Prod 67 (2004) 485-486
189. Ralph S.A., D'Ombrain M.C., and McFadden G.I. The apicoplast as an antimalarial drug target. Drug Resist Updat 4 (2001) 145-151
190. Ridley R.G. Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?. Proc Natl Acad Sci U S A 99 (2002) 13362-13364
191. Ridley R.G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 415 (2002) 686-693
192. Rios M.Y., and Aguilar-Guadarrama A.B. Nitrogen-containing phorbol esters from Croton ciliatoglandulifer and their effects on cyclooxygenases-1 and -2. J Nat Prod 69 (2006) 887-890
193. Robert A., and Meunier B. Is alkylation the main mechanism of action of the antimalarial drug artemisinin?. Chem Soc Rev 27 (1998) 273-279
194. Rochanakij S., Thebtaranonth Y., Yenjai C., and Yuthavong Y. Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture. Southeast Asian J Trop Med Public Health 16 (1985) 66-72
195. Rordorf C., Kellett N., Mair S., Ford M., Milosavljev S., Branson J., et al. Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects. Aliment Pharmacol Ther 18 (2003) 533-541
196. Roth G.J., Stanford N., and Majerus P.W. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A 72 (1975) 3073-3076
197. Rukachaisirikul T., Prabpai S., Champung P., and Suksamrarn A. Chabamide, a novel piperine dimer from stems of Piper chaba. Planta Med 68 (2002) 853-855
198. Rukachaisirikul T., Siriwattanakit P., Sukcharoenphol K., Wongvein C., Ruttanaweang P., Wongwattanavuch P., et al. Chemical constituents and bioactivity of Piper sarmentosum. J Ethnopharmacol 93 (2004) 173-176
199. Rukachaisirikul V., Pramjit S., Pakawatchai C., Isaka M., and Supothina S. 10-Membered macrolides from the insect pathogenic fungus Cordyceps militaris BCC 2816. J Nat Prod 67 (2004) 1953-1955
200. Rukachaisirikul V., Tansakul C., Saithong S., Pakawatchai C., Isaka M., and Suvannakad R. Hirsutane sesquiterpenes from the fungus Lentinus connatus BCC 8996. J Nat Prod 68 (2005) 1674-1676
201. Rukachaisirikul V., Chantaruk S., Pongcharoen W., Isaka M., and Lapanun S. Chromone derivatives from the filamentous fungus Lachnum sp. BCC 2424. J Nat Prod 69 (2006) 980-982
202. Rukachaisirikul V., Chantaruk S., Tansakul C., Saithong S., Chaicharernwimonkoon L., Pakawatchai C., et al. A cyclopeptide from the insect pathogenic fungus Cordyceps sp. BCC 1788. J Nat Prod 69 (2006) 305-307
203. Sahr F., Willoughby V.R., Gbakima A.A., and Bockarie M.J. Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports. Ann Trop Med Parasitol 95 (2001) 445-449
204. Salom I.L., Jacob G., Jallad N., Perdomo C.A., Mullane J.F., and Weidler D. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males. J Clin Pharmacol 24 (1984) 240-246
205. Santisuk T., and Larsen K. Flora of Thailand Alismataceae, Ponogetonaceae, Ctenolophanaceae, Cymodoceaceae, Hamamelidaceae, Hydrocharitaceae, Lemnaceae, Limnocharitaceae, Melastomataceae, Polygalaceae, Potamogetonaceae, Steruliaceae Vol. 7 Part 3 (2001), Forest Herbarium, Royal Forest Department, Bangkok
206. Sawadjoon S., Kittakoop P., Kirtikara K., Vichai V., Tanticharoen M., and Thebtaranonth Y. Atropisomeric myristinins: selective COX-2 inhibitors and antifungal agents from Myristica cinnamomea. J Org Chem 67 (2002) 5470-5475
207. Sawadjoon S., Kittakoop P., Isaka M., Kirtikara K., Madla S., and Thebtaranonth Y. Antiviral and antiplasmodial spirodihydrobenzofuran terpenes from the fungus Stachybotrys nephrospora. Planta Med 70 (2004) 1085-1087
208. Schuster F.L. Cultivation of Plasmodium spp. Clin Microbiol Rev 15 (2002) 355-364
209. Seephonkai P., Isaka M., Kittakoop P., Trakulnaleamsai S., Rattanajak R., Tanticharoen M., et al. A new tropolone from the insect pathogenic fungus Cordyceps sp. BCC 1681. J Antibiot (Tokyo) 54 (2001) 751-752
210. Seephonkai P., Isaka M., Kittakoop P., Palittapongarnpim P., Kamchonwongpaisan S., Tanticharoen M., et al. Evaluation of antimycobacterial, antiplasmodial and cytotoxic activities of preussomerins isolated from the lichenicolous fungus Microsphaeropsis sp. BCC 3050. Planta Med 68 (2002) 45-48
211. Seephonkai P., Kongsaeree P., Prabpai S., Isaka M., and Thebtaranonth Y. Transformation of an irregularly bridged epidithiodiketopiperazine to trichodermamide A. Org Lett 8 (2006) 3073-3075
212. 2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations. Biochemistry 40 (2001) 5172-5180
213. Sharma S.K., and Mohan A. Multidrug-resistant tuberculosis. Indian J Med Res 120 (2004) 354-376
214. Sharma S.K., Mohan A., Sharma A., and Mitra D.K. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 5 (2005) 415-430
215. Sikes D.H., Agrawal N.M., Zhao W.W., Kent J.D., Recker D.P., and Verburg K.M. Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. Eur J Gastroenterol Hepatol 14 (2002) 1101-1111
216. Silverstein F.E., Faich G., Goldstein J.L., Simon L.S., Pincus T., Whelton A., et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284 (2000) 1247-1255
217. Simpson D.A., and Koyama T. Cyperaceae Vol. 6 (1998), Forest Herbarium, Royal Forest Department, Bangkok
218. Singh V., Jaiswal A., Porter J.D., Ogden J.A., Sarin R., Sharma P.P., et al. TB control, poverty, and vulnerability in Delhi, India. Trop Med Int Health 7 (2002) 693-700
219. Sippel A., and Hartmann G. Mode of action of rafamycin on the RNA polymerase reaction. Biochim Biophys Acta 157 (1968) 218-219
220. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 82 (1990) 1107-1112
221. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 (1996) 33157-33160
222. Smitinand T., and Larsen K. Actinidiaceae, Apostasiaceae, Balanophoraceae, Bonnetiaceae, Cannabidaceae, Cardiopteridaceae, Casuarinaceae, Centrolepidaceae, Cephalotaxaceae, Connaraceae, Cupressaceae, Cycadaceae, Dilleniaceae, Ebenaceae, Elaeocarpaceae, Flagellariaceae, Gnetaceae, Goodeniaceae, Haloragaceae, Hanguanaceae, Hippocastanaceae, Icacinaceae, Illliciaceae, Irvingiaceae, Juncaceae, Lowiaceae, Magnoliaceae, Nyssaceae, Ochnaceae, Oxalidaceae, Pinaceae, Podocarpaceae, Portulacaceae, Rafflesiaceae, Restionaceae, Rhizophoraceae, Rosaceae, Saurauiaceae, Schisandraceae, Simaroubaceae, Smilacaceae, Sphenocleaceae, Stylidiaceae, Symplocaceae, Theaceae,Triuridaceae Vol. 2 (1981), TISTR Press, Bangkok
223. Smitinand T., and Larsen K. Scrophulariaceae Vol. 5 Part 2 (1990), Forest Herbarium, Royal Forest Department, Bangkok
224. Smitinand T., and Larsen K. Aizoaceae, Aralidiacea Vol. 9, Part 1 (2005), Forest Herbarium, Royal Forest Department, Bangkok
225. Solomon D.H., Schneeweiss S., Levin R., and Avorn J. Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44 (2004) 140-145
226. Solomon S.D., McMurray J.J., Pfeffer M.A., Wittes J., Fowler R., Finn P., et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352 (2005) 1071-1080
227. Sridhar C., Subbaraju G.V., Venkateswarlu Y., and Venugopal R.T. New acylated iridoid glucosides from Vitex altissima. J Nat Prod 67 (2004) 2012-2016
228. Sridhar C., Rao K.V., and Subbaraju G.V. Flavonoids, triterpenoids and a lignan from Vitex altissima. Phytochemistry 66 (2005) 1707-1712
229. Suksamrarn A., Kumpun S., Kirtikara K., Yingyongnarongkul B., and Suksamrarn S. Iridoids with anti-inflammatory activity from Vitex peduncularis. Planta Med 68 (2002) 72-73
230. Suksamrarn A., Poomsing P., Aroonrerk N., Punjanon T., Suksamrarn S., and Kongkun S. Antimycobacterial and antioxidant flavones from Limnophila geoffrayi. Arch Pharm Res 26 (2003) 816-820
231. Suksamrarn A., Tanachatchairatana T., and Kanokmedhakul S. Antiplasmodial triterpenes from twigs of Gardenia saxatilis. J Ethnopharmacol 88 (2003) 275-277
232. Suksamrarn S., Suwannapoch N., Phakhodee W., Thanuhiranlert J., Ratananukul P., Chimnoi N., et al. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem Pharm Bull (Tokyo) 51 (2003) 857-859
233. Suksamrarn A., Chotipong A., Suavansri T., Boongird S., Timsuksai P., Vimuttipong S., et al. Antimycobacterial activity and cytotoxicity of flavonoids from the flowers of Chromolaena odorata. Arch Pharm Res 27 (2004) 507-511
234. Suksamrarn A., Buaprom M., Udtip S., Nuntawong N., Haritakun R., and Kanokmedhakul S. Antimycobacterial and antiplasmodial unsaturated carboxylic acid from the twigs of Scleropyrum wallichianum. Chem Pharm Bull (Tokyo) 53 (2005) 1327-1329
235. Suksamrarn S., Panseeta P., Kunchanawatta S., Distaporn T., Ruktasing S., and Suksamrarn A. Ceanothane- and lupane-type triterpenes with antiplasmodial and antimycobacterial activities from Ziziphus cambodiana. Chem Pharm Bull (Tokyo) 54 (2006) 535-537
236. Sullivan Jr. D.J., Gluzman I.Y., and Goldberg D.E. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science 271 (1996) 219-222
237. Sunthitikawinsakul A., Kongkathip N., Kongkathip B., Phonnakhu S., Daly J.W., Spande T.F., et al. Coumarins and carbazoles from Clausena excavata exhibited antimycobacterial and antifungal activities. Planta Med 69 (2003) 155-157
238. Takayama K., and Kilburn J.O. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 33 (1989) 1493-1499
239. Tan-ariya P., Na-Bangchang K., Tin T., Limpaibul L., Brockelman C.R., and Karbwang J. Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand. Trans R Soc Trop Med Hyg 89 (1995) 426-429
240. Thebtaranonth C., Thebtaranonth Y., Wanauppathamkul S., and Yuthavong Y. Antimalarial sesquiterpenes from tubers of Cyperus rotundus: Structure of 10,12-peroxycalamenene, a sesquiterpene endoperoxide. Phytochemistry 40 (1995) 125-128
241. Thongtan J., Kittakoop P., Ruangrungsi N., Saenboonrueng J., and Thebtaranonth Y. New antimycobacterial and antimalarial 8,9-secokaurane diterpenes from Croton kongensis. J Nat Prod 66 (2003) 868-870
242. Tradional medicine. Fact Sheet No134 (2003), World Health Organization. http://www.who.int/mediacentre/factsheets/fs134/en/print.html Available: http://www.who.int/mediacentre/factsheets/fs134/en/print.html [2007, 12 February]
243. Triglia T., and Cowman A.F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci U S A 91 (1994) 7149-7153
244. Triglia T., and Cowman A.F. The mechanism of resistance to sulfa drugs in Plasmodium falciparum. Drug Resist Updat 2 (1999) 15-19
245. Tuchinda P., Reutrakul V., Claeson P., Pongprayoon U., Sematong T., Santisuk T., et al. Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata. Phytochemistry 59 (2002) 169-173
246. Tuntiwachwuttikul P., Pootaeng-on Y., Pansa P., Srisanpang T., and Taylor W.C. Sulfur-containing compounds from Clinacanthus siamensis. Chem Pharm Bull (Tokyo) 51 (2003) 1423-1425
247. Tuntiwachwuttikul P., Phansa P., Pootaeng-On Y., and Taylor W.C. Chemical constituents of the roots of Piper sarmentosum. Chem Pharm Bull (Tokyo) 54 (2006) 149-151
248. Tuntiwachwuttikul P., Phansa P., Pootaeng-On Y., and Taylor W.C. Chromones from the branches of Harrisonda perforata. Chem Pharm Bull (Tokyo) 54 (2006) 44-47
249. Uhlemann A.-C., Yuthavong Y., and Fidock D.A. Mechanisms of drug action and resistance. In: Sheman I.W. (Ed). Molecular approches to malaria (2005), ASM Press, New York 429-461
250. Ushikubi F., Segi E., Sugimoto Y., Murata T., Matsuoka T., Kobayashi T., et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395 (1998) 281-284
251. van Welzen P.C., and Chayamarit K. Flora of Thailand Euphorbiaceae (2005), Nationaal Herbarium Nederland. http://www.nationaalherbarium.nl/thaieuph Available: www.nationaalherbarium.nl/thaieuph [2006, 5 November]
252. Vander Jagt D.L., Hunsaker L.A., and Campos N.M. Comparison of proteases from chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum. Biochem Pharmacol 36 (1987) 3285-3291
253. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231 (1971) 232-235
254. Vongvanich N., Kittakoop P., Isaka M., Trakulnaleamsai S., Vimuttipong S., Tanticharoen M., et al. Hirsutellide A, a new antimycobacterial cyclohexadepsipeptide from the entomopathogenic fungus Hirsutella kobayasii. J Nat Prod 65 (2002) 1346-1348
255. Vongvilai P., Isaka M., Kittakoop P., Srikitikulchai P., Kongsaeree P., Prabpai S., et al. Isolation and structure elucidation of enniatins L, M-1, M-2, and N: novel hydroxy analogs. Helv Chim Acta 87 (2004) 2066-2073
256. Walker M.C., Kurumbail R.G., Kiefer J.R., Moreland K.T., Koboldt C.M., Isakson P.C., et al. A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. Biochem J 357 (2001) 709-718
257. Wallace J.L., and Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J 10 (1996) 731-740
258. Wallace J.L., and Ma L. Inflammatory mediators in gastrointestinal defense and injury. Exp Biol Med (Maywood) 226 (2001) 1003-1015
259. Wallace J.L., and Miller M.J. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119 (2000) 512-520
260. Wallace J.L., Reuter B.K., McKnight W., and Bak A. Selective inhibitors of cyclooxygenase-2: are they really effective, selective, and GI-safe?. J Clin Gastroenterol 27 Suppl 1 (1998) S28-S34
261. Wang P., Read M., Sim P.F., and Hyde J.E. Mutation in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A 23 (1997) 979-986
262. Weatherall D.J., Miller L.H., Baruch D.I., Marsh K., Doumbo O.K., Casals-Pascual C., et al. Malaria and the red cell. Hematol Am Soc Hematol Educ Program (2002) 35-57
263. Wei B.L., Lu C.M., Tsao L.T., Wang J.P., and Lin C.N. In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rhamnus species. Planta Med 67 (2001) 745-747
264. Wernsdorfer W.H. Chemoprophylaxis of malaria: Underlying priciples and their realization. Med Trop (Mars) 50 (1990) 119-124
265. Wernsdorfer W.H. The development and spread of drug-resistant malaria. Parasitol Today 7 (1991) 297-303
266. Wernsdorfer W.H. Epidemiology of drug resistance in malaria. Acta Trop 56 (1994) 143-156
267. Whitby M. Drug resistant Plasmodium vivax malaria. J Antimicrob Chemother 40 (1997) 749-752
268. White N.J. Drug resistance in malaria. Br Med Bull 54 (1998) 703-715
269. WHO. Tuberculosis Programme Review, India (1992), WHO, Geneva
270. Wiesner J., Ortmann R., Jomaa H., and Schlitzer M. New antimalarial drugs. Angew Chem Int Ed Engl 42 (2003) 5274-5293
271. Williams K., Davies S., and Middleton D. Botanical diversity and biogeography of peninsular Thailand, Salt Lake City, Utah (2004)
272. Willis A.L. Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion. J Pharm Pharmacol 21 (1969) 126-128
273. Winstanley P. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria. Trop Med Int Health 6 (2001) 952-954
274. Wolucka B.A., McNeil M.R., de Hoffmann E., Chojnacki T., and Brennan P.J. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J Biol Chem 269 (1994) 23328-23335
275. Wongsrichanalai C., Sirichaisinthop J., Karwacki J.J., Congpuong K., Miller R.S., Pang L., et al. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Southeast Asian J Trop Med Public Health 32 (2001) 41-49
276. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., and Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2 (2002) 209-218
277. Wongyai S. Country Report Thailand [Presentation] (2005) Bangkok
278. Woodrow C.J., Haynes R.K., and Krishna S. Artemisinins. Postgrad Med J 81 (2005) 71-78
279. Wu W.-M., Yao J.-J., Jiang K., and Wang Y.-F. Ferrous ion induced cleavage of the peroxy bond in quinghaosu and its derivatives and the DNA damage associated with this process. Chem Commun 18 (1996) 2213-2214
280. Yayon A., Cabantchik Z.I., and Ginsburg H. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc Natl Acad Sci U S A 82 (1985) 2784-2788
281. Yenjai C., Sripontan S., Sriprajun P., Kittakoop P., Jintasirikul A., Tanticharoen M., et al. Coumarins and carbazoles with antiplasmodial activity from Clausena harmandiana. Planta Med 66 (2000) 277-279
282. Yenjai C., Prasanphen K., Daodee S., Wongpanich V., and Kittakoop P. Bioactive flavonoids from Kaempferia parviflora. Fitoterapia 75 (2004) 89-92
283. Yeung S., Pongtavornpinyo W., Hastings I.M., Mills A.J., and White N.J. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg 71 (2004) 179-186
284. Zhang Y., and Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 7 (2003) 6-21
285. Zhang K., and Rathod P.K. Divergent regulation of dihydrofolate reductase between malaria parasite and human host. Science 296 (2002) 545-547
286. Zhang Y., Scorpio A., Nikaido H., and Sun Z. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol 181 (1999) 2044-2049
287. Zhang Y., Wade M.M., Scorpio A., Zhang H., and Sun Z. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52 (2003) 790-795